- Home
- WABC vs COGT Comparison
WABC vs COGT Comparison
Compare WABC & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WABC
- COGT
- Stock Information
- Founded
- WABC 1972
- COGT 2014
- Country
- WABC United States
- COGT United States
- Employees
- WABC N/A
- COGT N/A
- Industry
- WABC Major Banks
- COGT Biotechnology: Pharmaceutical Preparations
- Sector
- WABC Finance
- COGT Health Care
- Exchange
- WABC Nasdaq
- COGT Nasdaq
- Market Cap
- WABC 1.2B
- COGT 1.1B
- IPO Year
- WABC N/A
- COGT 2018
- Fundamental
- Price
- WABC $50.20
- COGT $12.08
- Analyst Decision
- WABC Hold
- COGT Strong Buy
- Analyst Count
- WABC 2
- COGT 10
- Target Price
- WABC $52.00
- COGT $20.22
- AVG Volume (30 Days)
- WABC 137.0K
- COGT 1.2M
- Earning Date
- WABC 10-16-2025
- COGT 08-05-2025
- Dividend Yield
- WABC 3.67%
- COGT N/A
- EPS Growth
- WABC N/A
- COGT N/A
- EPS
- WABC 4.79
- COGT N/A
- Revenue
- WABC $274,792,000.00
- COGT N/A
- Revenue This Year
- WABC N/A
- COGT N/A
- Revenue Next Year
- WABC N/A
- COGT N/A
- P/E Ratio
- WABC $10.47
- COGT N/A
- Revenue Growth
- WABC N/A
- COGT N/A
- 52 Week Low
- WABC $42.00
- COGT $3.72
- 52 Week High
- WABC $59.97
- COGT $12.97
- Technical
- Relative Strength Index (RSI)
- WABC 55.82
- COGT 57.94
- Support Level
- WABC $49.46
- COGT $11.77
- Resistance Level
- WABC $50.75
- COGT $12.84
- Average True Range (ATR)
- WABC 1.04
- COGT 0.53
- MACD
- WABC 0.17
- COGT -0.04
- Stochastic Oscillator
- WABC 76.08
- COGT 59.14
About WABC Westamerica Bancorporation
Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.